Caterina Rosano1, Subashan Perera2, Marco Inzitari3, Anne B Newman4, William T Longstreth5, Stephanie Studenski6. 1. University of Pittsburgh - Epidemiology, 130 N. Bellefield Ave., Pittsburgh, PA 15213, USA. 2. University of Pittsburgh - Geriatric Medicine, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA. 3. Universitat Autonoma de Barcelona Facultat de Biociencies Ringgold standard institution Bellaterra, Catalunya, Spain. 4. University of Pittsburgh - Graduate School of Public Health, Pittsburgh, PA, USA. 5. University of Washington - Neurology, Epidemiology, Seattle, WA, USA. 6. Harbor Hospital, 3001 Hanover Street, Baltimore, MD 21225, USA.
Abstract
OBJECTIVE: to examine whether psychomotor speed predicts individual and combined disorders in cognition, mobility and mood and if white matter hyperintensities explain these associations. DESIGN AND SETTING: longitudinal; Cardiovascular Health Study. SUBJECTS: 5,888 participants (57.6% women, 15.7% black, 75.1 (5.5), mean years (SD)). METHODS: psychomotor speed (Digit Symbol Substitution Test (DSST)) and small vessel disease (white matter hyperintensities (WMH)) were measured in 1992-94. Global cognition (Modified Mini-Mental State (3MS) examination), mobility (gait speed (GS)) and mood (Center for Epidemiologic Studies Depression (CES-D) scale) were measured annually over 5 years and classified as clinical, subclinical or no disorders based on established values (3MS: 80 and 85 points; GS: 0.6 and 1.0 m/s; CES-D: 10 and 5 points). Analyses were adjusted for demographics, baseline status, education, diabetes, hypertension, ankle-arm index. RESULTS: among those with no disorder in cognition, mobility and mood (N = 619) in 1992-94, being in the lowest DSST quartile compared to the highest was associated with nearly twice the odds of developing 1+ clinical or subclinical disorders (N = 413) during follow-up. Associations were stronger for incident clinical disorders in cognition (OR: 8.44, p < 0.01) or mobility (OR: 9.09, p < 0.05) than for mood (OR: 1.88, p < 0.10). Results were similar after adjustment for WMH. CONCLUSIONS: slower psychomotor speed may serve as a biomarker of risk of clinical disorders of cognition, mobility and mood. While in part attributable to vascular brain disease, other potentially modifiable contributors may be present. Further studying the causes of psychomotor slowing with ageing might provide novel insights into age-related brain disorders.
OBJECTIVE: to examine whether psychomotor speed predicts individual and combined disorders in cognition, mobility and mood and if white matter hyperintensities explain these associations. DESIGN AND SETTING: longitudinal; Cardiovascular Health Study. SUBJECTS: 5,888 participants (57.6% women, 15.7% black, 75.1 (5.5), mean years (SD)). METHODS: psychomotor speed (Digit Symbol Substitution Test (DSST)) and small vessel disease (white matter hyperintensities (WMH)) were measured in 1992-94. Global cognition (Modified Mini-Mental State (3MS) examination), mobility (gait speed (GS)) and mood (Center for Epidemiologic Studies Depression (CES-D) scale) were measured annually over 5 years and classified as clinical, subclinical or no disorders based on established values (3MS: 80 and 85 points; GS: 0.6 and 1.0 m/s; CES-D: 10 and 5 points). Analyses were adjusted for demographics, baseline status, education, diabetes, hypertension, ankle-arm index. RESULTS: among those with no disorder in cognition, mobility and mood (N = 619) in 1992-94, being in the lowest DSST quartile compared to the highest was associated with nearly twice the odds of developing 1+ clinical or subclinical disorders (N = 413) during follow-up. Associations were stronger for incident clinical disorders in cognition (OR: 8.44, p < 0.01) or mobility (OR: 9.09, p < 0.05) than for mood (OR: 1.88, p < 0.10). Results were similar after adjustment for WMH. CONCLUSIONS: slower psychomotor speed may serve as a biomarker of risk of clinical disorders of cognition, mobility and mood. While in part attributable to vascular brain disease, other potentially modifiable contributors may be present. Further studying the causes of psychomotor slowing with ageing might provide novel insights into age-related brain disorders.
Authors: A B Newman; L Shemanski; T A Manolio; M Cushman; M Mittelmark; J F Polak; N R Powe; D Siscovick Journal: Arterioscler Thromb Vasc Biol Date: 1999-03 Impact factor: 8.311
Authors: Mark A Espeland; Stephen R Rapp; Julia Robertson; Iris Granek; Carol Murphy; Marilyn Albert; Tamsen Bassford Journal: Clin Trials Date: 2006 Impact factor: 2.486
Authors: R N Bryan; T A Manolio; L D Schertz; C Jungreis; V C Poirier; A D Elster; R A Kronmal Journal: AJNR Am J Neuroradiol Date: 1994-10 Impact factor: 3.825
Authors: N L Watson; C Rosano; R M Boudreau; E M Simonsick; L Ferrucci; K Sutton-Tyrrell; S E Hardy; H H Atkinson; K Yaffe; S Satterfield; T B Harris; A B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2010-06-25 Impact factor: 6.053
Authors: Ihab Hajjar; Frances Yang; Farzaneh Sorond; Richard N Jones; William Milberg; L Adrienne Cupples; Lewis A Lipsitz Journal: J Gerontol A Biol Sci Med Sci Date: 2009-06-17 Impact factor: 6.053
Authors: Marco Inzitari; Andrea Metti; Caterina Rosano; Cristina Udina; Laura M Pérez; Gabriela Carrizo; Joe Verghese; Anne B Newman; Stephanie Studenski; Andrea L Rosso Journal: Exp Gerontol Date: 2019-07-06 Impact factor: 4.032
Authors: Stacy L Andersen; Benjamin Sweigart; Nancy W Glynn; Mary K Wojczynski; Bharat Thyagarajan; Jonas Mengel-From; Stephen Thielke; Thomas T Perls; David J Libon; Rhoda Au; Stephanie Cosentino; Paola Sebastianion Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Sarah T Stahl; Helene M Altmann; Mary Amanda Dew; Steven M Albert; Meryl Butters; Ariel Gildengers; Charles F Reynolds; Jordan F Karp Journal: J Am Geriatr Soc Date: 2021-01-02 Impact factor: 5.562